Introduction {#s1}
============

For many years, COPD was mainly explained by an accelerated loss of pulmonary function (PF) in adult smokers \[[@C1]\]~.~ Recently, many studies have supported the existence of other PF trajectories patterns leading to several lung diseases in addition to COPD \[[@C2]--[@C4]\]. These trajectories are ones in which individuals experience a 'physiological' decline rate, having achieved only submaximal values of PF at the beginning of adulthood \[[@C5], [@C6]\].

Different PF trajectories are determined by different living conditions, shared habits and other exposures during the early-life PF developmental phase \[[@C3], [@C4], [@C7], [@C8]\]. Considering the methodological challenges in evaluating repeated measures of PF, few longitudinal and population-based studies have investigated PF trajectories throughout the life course. Up to date, all published studies are based on populations living in high-income countries \[[@C3], [@C7]--[@C9]\].

Submaximal levels of forced expiratory volume in 1 s (FEV~1~) or forced vital capacity (FVC) at the beginning of adulthood are associated not only with respiratory diseases \[[@C3], [@C6]--[@C8]\] but also with premature death \[[@C10]--[@C13]\] and the occurrence of comorbidities, such as diabetes \[[@C6]\], cancer \[[@C11], [@C12]\] and cardiovascular diseases \[[@C6], [@C13]\]. In this context, predicting the risky trajectories along with their associated determinants may inform measures to maximise the PF of adolescents and young adults and avoid future chronic diseases.

The purpose of this study was to establish the PF growth trajectories from 15 to 22 years of age in the Pelotas 1993 Birth Cohort, Brazil, characterising them according to socioeconomic, gestational, perinatal, environmental, behavioural and health determinants during the life course.

Methods {#s2}
=======

We used data from the population-based Pelotas 1993 Birth Cohort, in Rio Grande do Sul state, Brazil. The cohort aimed to evaluate all live births between January 1 and December 31, 1993, whose mothers lived in the urban area of Pelotas municipality. Of the 5265 eligible pairs of mothers and children, 5249 individuals (99.7%) were recruited at baseline. At 6 and 12 months and at 4 years of age, all newborns with low birth weight (\<2500 g) and a random sample of 20% of the original cohort were included, (n=1460 children). From 11 years onwards, all the original cohort members were evaluated. More cohort details can be found in a previous publication \[[@C14]\].

All the follow-up visits of the 1993 Pelotas Birth Cohort were approved by the Ethics and Research Committee of the Faculty of Medicine of the Federal University of Pelotas (UFPel), with the recent follow-up under the 1.250.366 protocol. Informed consent was obtained from all members of the cohort or their guardians when they were under-aged.

Pulmonary function {#sa}
------------------

Spirometry was conducted at 15, 18 and 22 years of age using a portable spirometer (Easy-one, ndd Medical Technologies). A maximum of eight forced expiratory manoeuvres were performed, aiming for three acceptable manoeuvres with \<150 mL variation between the two highest measurements following the quality standards of the American Thoracic Society and the European Respiratory Society \[[@C15], [@C16]\]. We avoided spirometry in individuals with diagnosed cardiac alterations and those who reported thoracic, abdominal or ocular surgery, retinal displacement and hospitalisations due to cardiac problems in the last 3 months, pregnant women and individuals who were referred with active tuberculosis. Pre-bronchodilator values of FEV~1~ and FVC were expressed in z-scores according to internal reference values generated from the standardised residuals of a linear regression with sex, skin colour and height as predictors.

Characteristics of PF trajectory {#sb}
--------------------------------

We used information on potential determinants of PF trajectory collected in either the perinatal period, at 6 and 12 months or 4, 11, 15, 18 and 22 years of age. All variables were collected through standardised measures and questionnaires.

From the perinatal follow-up interview, details on family income in minimum wages per month in Brazilian currency (a minimum wage equivalent to approximately US\$84), birth weight (g), prematurity (gestational age \<37 weeks), pregestational body mass index (BMI), weight and height reported by mothers and calculated in kg·m^−2,^ following the World Health Organisation (WHO) \[[@C17]\] standards, mother\'s and father\'s smoking and any maternal alcohol consumption during pregnancy were collected. Hospitalisations due to respiratory diseases (bronchitis, bronchiolitis, pneumonia and other respiratory diseases) from birth to 6 months and from 6 to 12 months were recorded. At 12 months, child\'s wheezing in the last 6 months and exposure to father\'s or mother\'s smoking after birth were also assessed and were all self-reported.

At 4, 11, 15, 18 and 22 years of age, BMI was calculated in kg·m^−2^ and expressed as age-adjusted z-scores, according to WHO guidelines \[[@C18]\]. Details about height and weight measurements are presented in the [supplementary materials](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00065-2020.figures-only#fig-data-supplementary-materials).

Self-reported physical activity from 11 to 22 years of age, was collected by a list of activities, and at age 18, using the International Physical Activity Questionnaire \[[@C19]\]. From these activities, frequency, duration and intensity were measured, generating a physical activity score in minutes per week according to WHO guidelines \[[@C20]\].

At 4, 11 and 15 years, wheezing in the last 12 months and diagnosis of asthma were collected. At the two older ages, allergy diagnosis was also reported. Family history of asthma was recorded at the 11-year follow-up. In the 4- and 11-year follow-ups, maternal and paternal smoking status were questioned. Hospitalisation cases due to respiratory diseases (asthma, wheezing and bronchitis) from 12 months to 4 years old were also assessed.

At 18 and 22 years old, we analysed smoking status, exposure to other resident\'s smoke at home, asthma and allergy diagnosis and wheezing reported in the last 12 months. Only at 18 years were the mother and father\'s smoking statuses recorded.

Statistical analysis {#s2c}
--------------------

To assess selection bias, perinatal characteristics of cohort members included (n=2917) and not included (n=2332) in the analysis were compared.

PF trajectories were identified by a group-based trajectory model approach \[[@C21]\]. The best model was chosen according to Bayesian and Akaike information criteria \[[@C22]\] but was also supported by other parameters \[[@C23]\]: 1) an average posterior probability; 2) the odds of correct classification; and 3) correspondence between estimated and assigned group probabilities ([supplementary table S1](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00065-2020.figures-only#fig-data-supplementary-materials)). We compared the prevalence or characteristic means with each trajectory using the Chi-squared test and ANOVA. As participants with low birth weight were over-represented at 6 and 12 months and 4 years of age, when we included variables from these follow-ups, sample weights were applied to consider this oversampling. A significance level of 5% was considered as significant. All analyses were undertaken using Stata version 16 (StataCorp, College Station, TX, USA).

Results {#s3}
=======

The final sample consisted of 2917 individuals who had PF measurements in all follow-up visits. The study population differed from the nonrespondent\'s group in relation to income and maternal education ([supplementary table S2](http://openres.ersjournals.com/lookup/doi/10.1183/23120541.00065-2020.figures-only#fig-data-supplementary-materials)). Those included were wealthier and were less likely to have mothers with a lower educational level.

For each PF parameter, three PF trajectories were identified ([figure 1](#F1){ref-type="fig"}): low (\<−1 z-scores), average and high (\>1 z-scores). Most individuals were classified in the AT of both FEV~1,~ (59.6%) and FVC (58.8%) and in the HT of their ratio (47.2%).

![a) Pulmonary function (PF) trajectories based on forced expiratory volume in 1 s (FEV~1~) values expressed in z-scores; b) PF trajectories based on forced vital capacity (FVC) values expressed in z-scores; c) PF trajectories based on FEV~1~/ FVC ratio.](00065-2020.01){#F1}

Gestational and perinatal characteristics and PF trajectories are shown in [table 1](#TB1){ref-type="table"}. Income was higher in the HT (4.66±0.22) and LT (4.56±0.34) of FEV~1~ and lower in the AT (4.04±0.12) (p=0.023). No differences were observed for the other PF parameters. The proportion of men was lower in the AT of both FEV~1~ and FVC (45.6% and 45.9% respectively; p\<0.001) and in the HT of their ratio (41.2%; p\<0.001). Low maternal pregestational BMI (22.4±0.2 and 22.1±0.14) and lower birth weight (3164.8±25.4 and 3132.3±19.4) were associated with the LT of FEV~1~ and FVC, respectively. A higher proportion of mother\'s smoking exposure was observed in the LT of FEV~1~/FVC ratio during all gestational periods but was statistically significant only in the first trimester (p=0.002). No differences were found when father\`s smoke exposure was evaluated.

###### 

Description of the gestational and perinatal covariates for each group of pulmonary function trajectories: the 1993 Pelotas Birth Cohort, Brazil

                                             **FEV~1~**      **FVC**     **FEV~1~/ FVC**                                                                                                                  
  ----------------------------------------- ------------- ------------- ----------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- ------------- -------------
  **Income (minimum wages)** ^¶\#^            4.56±0.34     4.04±0.12       4.66±0.22       **0.023**     4.04±0.21     4.27±0.13     4.48±0.24       0.381       4.54±0.42     4.20±0.15     4.27±0.15       0.964
  **Male sex %**                             245 (56.3)    809 (45.6)      381 (54.0)      **\<0.001**   348 (54.8)    760 (45.9)    327 (52.3)    **\<0.001**   153 (61.4)    710 (55.5)    572 (41.2)    **\<0.001**
  **Birth weight g**^¶^                      3164.8±25.4   3175.8±12.4     3232.0±19.8      **0.029**    3132.3±19.4   3195.1±13.0   3224.8±21.6    **0.005**    3240.1±37.3   3204.3±14.7   3163.3±13.7    **0.034**
  **Prematurity (%)**                         51 (13.4)    160 (10.1)       65 (10.2)         0.151       71 (13.0)     141 (9.5)     64 (11.2)       0.072       30 (13.1)     106 (9.3)    140 (11.4)       0.144
  **Pregestational BMI kg**·**m^−2^** ^¶^     22.4±0.2      22.8±0.1        23.3±0.1       **\<0.001**    22.1±0.14     23.0±0.1      23.3±0.15    **\<0.001**    23.0±0.25     23.1±0.10     22.6±0.10     **0.006**
  **Smoking in pregnancy %**                                                                                                                                                                              
  1° trimester                               133 (30.6)    499 (28.1)      220 (31.0)         0.252      177 (27.9)    470 (28.4)    205 (32.8)       0.081       94 (37.7)    384 (30.0)    374 (26.9)     **0.002**
  2° trimester                               126 (29.0)    474 (26.7)      206 (29.2)         0.364      168 (26.4)    446 (26.9)    192 (30.7)       0.146       82 (32.9)    360 (28.1)    364 (26.2)       0.079
  3° trimester                               120 (27.6)    469 (26.4)      203 (28.7)         0.483      156 (24.6)    447 (27.0)    189 (30.2)       0.075       82 (32.9)    353 (27.6)    357 (25.7)       0.055
  **Father\'s smoke %**                      182 (41.8)    815 (45.9)      309 (43.9)         0.259      283 (44.5)    750 (45.3)    273 (43.7)       0.789       97 (38.9)    568 (44.4)    641 (46.1)       0.103
  **Alcohol in pregnancy %**                  17 (3.9)      93 (5.2)        40 (5.7)          0.409       28 (4.4)      88 (5.3)      34 (5.4)        0.635       14 (5.6)      60 (4.7)      76 (5.5)        0.619

Data are presented as mean±[sd]{.smallcaps} or n (%), unless otherwise stated. p-values were obtained by the Chi-squared test, unless otherwise stated. FEV~1~: forced expiratory volume in 1 s; FVC: forced vital capacity; BMI: body mass index. ^\#^: family income in minimum wages per month in Brazilian currency (a minimum wage equivalent to approximately US\$84). ^¶^: p-value obtained by ANOVA. N: absolute frequencies of individuals per pulmonary function (PF) trajectories based on the total sample (2197); n: absolute frequencies of the exposure covariables per PF trajectory.

[Table 2](#TB2){ref-type="table"} describes the respiratory covariates, tobacco exposure after birth and physical activity and PF trajectories. The frequency of hospitalisations due to respiratory diseases was significantly higher in the LT of FEV~1~ at 6 months (p=0.027) and in the LT of FEV~1~/FVC ratio at 6 months (p=0.035) and 4 years of age (p=0.001). At almost all evaluated ages, wheezing and asthma diagnoses were higher in the LT of both FEV~1~ and FEV~1~/FVC ratio. The latter was also related to a family history of asthma (p\<0.001). Higher frequencies of allergy diagnosis were reported in the HT of FEV~1~ (p=0.015) and FVC (p=0.024) at ages 15 and 22 years, respectively and in the LT of their ratio at ages 11, 18 and 22 years (p\<0.05). At 18 and 22 years, current smoking was strongly related to the LT of FEV~1~/FVC ratio (p\<0.001). Despite not being statistically significant, the same can be applied to the HT of FVC at both ages. More active people were prevalent in the LT of FEV~1~/FVC ratio at 15 (p\<0.001) and 18 years (p=0.021).

###### 

Description of the respiratory, smoke exposure and physical activity covariates collected after birth for each group of pulmonary function trajectories: the 1993 Pelotas Birth Cohort, Brazil

                                                     **FEV~1~**    **FVC**     **FEV~1~/ FVC**                                                                                                           
  ------------------------------------------------- ------------ ------------ ----------------- ------------- ------------ ------------ ------------ ----------- ------------ ------------- ------------ -------------
  **Hospitalisation due to respiratory diseases**                                                                                                                                                        
  6 months                                           17 (12.2)     33 (6.3)        9 (4.0)        **0.027**     18 (8.3)     35 (7.1)     6 (3.7)       0.275      8 (13.7)     28 (7.7)      23 (4.8)     **0.035**
  12 months                                           7 (3.4)      18 (2.9)        7 (3.8)          0.850       9 (2.2)      18 (3.5)     5 (3.6)       0.661      2 (3.8)      14 (3.4)      16 (2.9)       0.914
  4 year                                             22 (14.9)    64 (11.0)       13 (6.1)          0.073       22 (7.2)    62 (12.2)     15 (8.7)      0.139     16 (22.8)     44 (11.7)     39 (7.4)     **0.001**
  **Wheezing (last 12 months)**                                                                                                                                                                          
  12 months                                          68 (54.1)    228 (46.6)      80 (43.1)         0.134      85 (48.1)    223 (47.7)   68 (43.1)      0.605     38 (58.6)    159 (48.9)    179 (43.5)      0.053
  4 years                                            29 (22.5)    98 (20.0)       27 (15.7)         0.169      31 (17.0)    99 (21.5)    24 (15.3)      0.315     18 (26.7)     78 (23.9)    58 (14.4)     **0.005**
  11 years                                           87 (20.4)    234 (13.4)      76 (10.9)      **\<0.001**   90 (14.5)    232 (14.2)   75 (12.1)      0.420     67 (27.6)    200 (15.9)    130 (9.5)    **\<0.001**
  15 years                                           67 (15.4)    194 (10.9)      71 (10.1)       **0.014**    71 (11.2)    186 (11.2)   75 (12.0)      0.860     49 (19.7)    156 (12.2)    127 (9.1)    **\<0.001**
  18 years                                           71 (16.3)    223(12.6)       66 (9.3)        **0.002**    75 (11.8)    215 (13.0)   70 (12.2)      0.465     58 (23.3)    165 (12.9)    137 (9.8)    **\<0.001**
  22 years                                           68 (15.7)    174 (9.8)       50 (7.1)       **\<0.001**    61 (9.6)    162 (9.8)    69 (11.1)      0.618     69 (27.9)    136 (10.6)     87 (6.3)    **\<0.001**
  **Asthma diagnosis**                                                                                                                                                                                   
  4 years                                             5 (4.8)      8 (1.62)       2 (1.14)          0.133       2 (0.9)      13 (2.9)        \-         0.068      3 (4.4)       5 (1.7)      7 (1.8)        0.404
  11 years                                           158 (37.1)   481 (27.5)     162 (23.2)      **\<0.001**   180 (29.0)   454 (27.8)   167 (27.0)     0.778     120 (49.4)   390 (31.0)    291 (21.2)   **\<0.001**
  15 years                                           161 (37.1)   516 (29.1)     162 (23.0)      **\<0.001**   188 (29.6)   480 (30.0)   171 (27.4)     0.675     124 (50.0)   409 (32.0)    306 (22.5)   **\<0.001**
  18 years                                           125 (28.7)   381 (21.5)     115 (16.3)      **\<0.001**   125 (19.7)   364 (22.0)   132 (21.0)     0.479     107 (43.0)   310 (24.3)    204 (14.7)   **\<0.001**
  22 years                                           131 (30.1)   407 (22.9)     120 (17.0)      **\<0.001**   140 (22.0)   382 (23.1)   136 (21.6)     0.745     109 (43.9)   317 (24.8)    232 (16.7)   **\<0.001**
  **Allergy diagnosis**                                                                                                                                                                                  
  11 years                                           79 (18.5)    298 (17.0)     142 (20.4)         0.146      104 (16.7)   293 (17.9)   122 (19.9)     0.343     58 (23.9)    223 (17.7)    238 (17.3)    **0.047**
  15 years                                           99 (22.9)    339 (19.2)     169 (24.1)       **0.015**    121 (19.1)   335 (20.3)   151 (24.2)     0.057     59 (23.9)    270 (21.2)    278 (20.1)      0.375
  18 years                                           92 (21.2)    349 (19.6)     20.6 (20.6)        0.714      109 (17.2)   350 (21.1)   127 (20.3)     0.111     68 (27.3)    246 (19.2)    272 (19.6)    **0.012**
  22 years                                           97 (22.4)    433 (24.4)     179 (25.4)         0.520      128 (20.2)   422 (25.5)   159 (25.5)   **0.024**   75 (30.2)    283 (22.1)    351 (25.3)    **0.012**
  **Family history of asthma**                                                                                                                                                                           
  11 years                                           165 (38.7)   588 (33.6)     230 (33.0)         0.100      222 (35.7)   537 (32.8)   224 (36.5)     0.178     109 (44.8)   465 (37.0)    409 (29.8)   **\<0.001**
  **Mother\'s smoke**                                                                                                                                                                                    
  After 6 months                                     38 (24.7)    193 (34.7)      75 (40.2)         0.147      64 (29.3)    171 (33.4)   71 (43.2)      0.126     26 (31.3)    139 (39.1)    141 (31.0)      0.08
  4 years                                            32 (20.8)    181 (33.6)      68 (36.7)         0.070      58 (26.3)    159 (32.2)   64 (39.9)      0.125     25 (34.6)    121 (33.6)    135 (30.9)      0.728
  11 years                                           126 (29.6)   553 (31.6)     191 (24.4)         0.116      177 (28.4)   508 (31.0)   185 (30.2)     0.491     87 (35.8)    390 (31.0)    393 (28.6)      0.059
  18 years                                           93 (21.4)    384 (21.8)     160 (22.8)         0.824      131 (20.7)   367 (22.3)   139 (22.3)     0.707     58 (23.4)    289 (22.7)    290 (21.0)      0.471
  **Father\'s smoke**                                                                                                                                                                                    
  After 6 months                                     44 (34.4)    169 (32.9)      54 (29.9)         0.519      66 (35.8)    150 (30.6)   51 (32.9)      0.347     22 (28.4)     95 (29.7)    150 (34.8)      0.335
  4 years                                            38 (28.9)    143 (28.6)      46 (24.8)         0.609      55 (29.1)    131 (27.4)   41 (27.2)      0.549     22 (31.7)     83 (25.1)    122 (29.3)      0.418
  11 years                                           124 (38.6)   502 (37.1)     190 (34.4)         0.395      174 (37.1)   464 (36.2)   178 (37.3)     0.889     67 (36.2)    361 (36.9)    388 (36.5)      0.963
  18 years                                           74 (17.0)    269 (15.2)     113 (16.1)         0.625      94 (14.9)    267 (16.2)   95 (15.3)      0.695     36 (14.5)    195 (15.3)    225 (16.9)      0.691
  **Household smoke exposure**                                                                                                                                                                           
  18 years                                           196 (45.2)   745 (42.2)     299 (42.6)         0.546      264 (41.8)   715 (43.4)   261 (42.1)     0.708     108 (43.6)   549 (43.2)    583 (42.2)      0.842
  22 years                                           137 (31.6)   569 (32.1)     212 (29.9)         0.607      194 (30.6)   528 (31.9)   196 (31.4)     0.838     84 (33.9)    391 (30.6)    443 (31.9)      0.527
  **Current smoker**                                                                                                                                                                                     
  18 years                                           55 (12.6)    230 (12.9)      96 (13.6)         0.876      71 (11.2)    212 (12.8)   98 (15.7)      0.054     50 (20.1)    192 (15.0)    139 (10.0)   **\<0.001**
  22 years                                           80 (18.4)    291 (16.4)     100 (14.6)         0.153      86 (13.6)    274 (16.6)   111 (17.8)     0.103     64 (25.8)    235 (18.4)    471 (16.1)   **\<0.001**
  **Physical activity min**^\#^                                                                                                                                                                          
  11 years                                           431.0±24.3   432.2±11.0     440.8±18.9         0.911      421.2±18.7   432.6±11.5   450.9±20.6     0.535     458.9±32.3   461.1±14.0    404.9±12.1    **0.007**
  15 years                                           482.9±26.2   438.7±11.7     455.1±18.0         0.239      434.5±18.0   437.7±18.1   468.1±20.5     0.516     525.6±42.2   481.2±14.4    406.2±11.9   **\<0.001**
  18 years                                           643.4±31.0   658.3±19.8     683.7±27.4         0.663      639.1±28.9   658.8±20.2   694.8±29.8     0.435     771.8±47.7   676.8.±20.4   629.2±22.4    **0.021**
  22 years                                           377.8±24.8   335.7±10.2     335.3±13.5         0.163      359.3±20.0   335.7±10.1   340.4±15.2     0.495     379.1±31.5   352.9±12.0    325.1±11.0      0.088

Data are presented as n (%) or mean±[sd]{.smallcaps}, unless otherwise stated. p-values were obtained by the Chi-squared test, unless otherwise stated. FEV~1~: forced expiratory volume in 1 s; FVC: forced vital capacity. ^\#^: p-value was obtained by ANOVA (mean±[sd]{.smallcaps}). Due to sample design at 6 and 12 months and 4 years of age (all births \<2500 g and a 20% sample of the remaining children), relative frequencies were weighted to reproduce the original cohort distribution. N: absolute frequencies of individuals per pulmonary function (PF) trajectories based on the total sample (2197); n: absolute frequencies of the exposure covariables per PF trajectory. Total sample at 6 and 12 months and at 4 and 11 years of age with PF measurements at all three follow-ups was 830, 813, 755 and 1876, respectively.

The relationship between BMI and PF trajectories are shown in [figure 2](#F2){ref-type="fig"}. At all ages, higher BMI means were observed in the HT of FEV~1~ and FVC (p\<0.001) and in the LT of their ratio (p\<0.001). [Figure 3](#F3){ref-type="fig"} shows the individual obstruction status, represented by the FEV~1~/FVC ratio values for each PF trajectory. At all ages, lower percentage means of FEV~1~/FVC ratio were observed in the LT of FEV~1~ (p\<0.001) and in the HT of FVC (p\<0.001).

![BMI/age (z-scores) and pulmonary function (PF) trajectories based on a) forced expiratory volume in 1 s (FEV~1~); b) forced vital capacity (FVC) and c) FEV~1~/ FVC ratio.](00065-2020.02){#F2}

![Description of the forced expiratory volume in 1 s (FEV~1~)/ forced vital capacity (FVC) ratio means for each trajectory group based on a) FEV~1~ and b) FVC.](00065-2020.03){#F3}

Discussion {#s4}
==========

We observed three trajectories showing high, average and low patterns of PF. These trajectories were tracked over a 7-year period ([figure 1](#F1){ref-type="fig"}). Following a lower trajectory from 15 to 22 years of age was associated with: lower income, mothers with lower pregestational BMI, lower birth weight, higher instances of hospitalisation due to respiratory diseases in childhood, lower BMI, more wheezing, medical diagnosis and family history of asthma, gestational exposure to tobacco and current smoking status. To the best of our knowledge, this is the first study to characterise PF trajectory groups in a birth cohort from a middle-income country.

The ability to detect PF trajectories in longitudinal data is dependent on the sample size and the number of measures on each individual \[[@C24]\]. In both the \[[@C7]\], Manchester Asthma Allergy Study Cohort (MASS) (1046 participants, PF measured at ages 5, 8, 11 and 16 years) and Avon Longitudinal Study of Parents and Children (ALSPAC) (1390 participants, PF measured at ages 8, 15 and 24 years), the authors observed four trajectories that were tracked over the observation period. Two of them presented persistently below average values until adulthood, and included more than half of the sample. The Tasmanian Longitudinal Health Study Cohort (TAHS) \[[@C3]\], described six PF trajectories (2438 participants, PF measured at 7, 13, 18, 45, 50 and 53 years). Among these trajectories, around 42% of the sample presented PF trajectories always below the mean. Unlike our study, more than half of the sample presented average values of PF over time. The above-mentioned studies presented sample sizes similar to ours; however, they detected more trajectories and also a higher percentage of individuals with low PF due to a longer follow-up time that spanned childhood to the sixth decade of life \[[@C3]\] and into a slightly older age than our study \[[@C7]\]. The Tucson Children Respiratory Study (CRS) \[[@C8]\] (599 participants, PF measured from 11 to 32 years) and the Isle of Wight (IOW) cohort \[[@C9]\] (around 1000 participants, PF measured at 10, 18 and 26 years) only showed high and low PF trajectories, probably due to their small sample size.

A higher mean income was observed in individuals in the HT and LT of FEV~1~ ([table 1](#TB1){ref-type="table"}). This result supports socioeconomic status as a determinant of PF as it can provide information regarding respiratory health inequalities \[[@C25]\]. However, as our results are not linear, further investigations could explore the role of socioeconomic status in lung function trajectories. A previous study in the same cohort showed that individuals in the lowest socioeconomic groups from birth to adolescence also had lower PF at age 15 years \[[@C26]\].

A lower maternal pregestational BMI was observed in the LT of FVC and FEV~1~ ([table 1](#TB1){ref-type="table"})~,~ and this can be explained by its association with birth weight. Maternal malnutrition may have a direct impact on birth weight as a result of nutrient-deficient transplacental transport \[[@C27]\]. In our cohort, lower maternal BMI was significantly associated with low birth weight (results not shown) which was also associated with the LT of both FVC and FEV~1~ in this study~.~ Lower birth weight is a well-established risk factor for low PF in adulthood. A recent meta-analysis \[[@C28]\] showed a strong association of high birth weight and greater PF later in life. Similarly to our results, the IOW study \[[@C9]\] showed that low birth weight was strongly related to low trajectories of PF. Also, findings from the MASS and ALSPAC study \[[@C7]\], presented the same pattern, despite not being different statistically.

Mother\'s smoke exposure during pregnancy ([table 1](#TB1){ref-type="table"}) and current smoking at 18 and 22 years ([table 2](#TB2){ref-type="table"}) were related to the LT of FEV~1~/FVC ratio. There is clear evidence that *in utero* tobacco exposure results in PF deficits in infancy that tracks into adulthood \[[@C29]\]. It was already associated with a reduction in FEV~1~ in 21-year-old men \[[@C30]\] and in the FEV~1~/FVC ratio measured at 16 years \[[@C31]\]. The TAHS study \[[@C3]\] showed that current smoking status was associated with submaximal PF trajectories at adulthood and an interaction between maternal and personal smoking for the risk of belonging to the lower PF trajectory. Despite not being statistically significant, higher smoke exposure was related to the HT of FVC ([table 2](#TB2){ref-type="table"}). However, lower values of FEV~1~/FVC ratio were also shown in this trajectory ([figure 3](#F3){ref-type="fig"}). Thus, our findings demonstrated agreement between high FVC and low FEV~1~/FVC trajectories as complementary signals for airflow obstruction and its relation to tobacco smoke exposure. The same pattern was already described; while the FVC level was higher in smokers, the rates of FVC and FEV~1~ growth were reduced \[[@C32]\].

Regarding the history of respiratory conditions, the frequency of hospitalisations due to respiratory diseases was significantly higher in the LT of FEV~1~ and FEV~1~/FVC ratio. Similarly, in the MAAS cohort \[[@C7]\], the proportion of children with lower respiratory tract infections in the first 3 years of life was higher in the persistently LT of FEV~1~ compared to the normal trajectory. Also, the proportion of bronchitis and pneumonia was higher in the three trajectories represented by always below average values of PF in the TAHS study \[[@C3]\]. The diagnoses of asthma, allergy and wheezing were associated with the LT of FEV~1~ and FEV~1~/FVC ([table 2](#TB2){ref-type="table"}). The MASS and ALSPAC cohorts \[[@C7]\] also identified associations between a reduced FEV~1~ trajectory with wheezing and asthma. Similarly, in the TAHS study \[[@C3]\], individuals whose PF was considered persistently below average had a higher prevalence of asthma and in the IOW cohort \[[@C9]\], asthma was related to the lower trajectories of FEV~1,~ FEV~1~/FVC and forced expiratory flow at 25--75% of FVC in men. A meta-analysis \[[@C33]\] enrolling large samples of wheezing and nonwheezing children, concluded a reduction in FEV~1~ and FEV~1~/FVC ratio in adulthood between those who reported wheezing. Indeed, the same pattern was observed in our sample. The family history of asthma was associated with the LT of FEV~1~/FVC ratio ([table 2](#TB2){ref-type="table"}). Another study associated paternal asthma with a lower increase in FEV~1~ and low FEV~1~/FVC ratio from 8 to 16 years \[[@C34]\]. In the CRS cohort, individuals with a persistently low PF trajectory were more likely to have asthmatic mothers \[[@C8]\].

At all ages, higher BMI means were linked to the HT of FEV~1~ and FVC ([figure 2](#F2){ref-type="fig"}). A study \[[@C35]\], showed higher lean BMI (LBMI) related to PF growth and higher fat mass index (FMI) was associated with worse FEV~1~ in boys and FEV~1~/FVC in both sexes. As an increase in both LBMI and FMI will increase BMI, and these findings support that BMI itself may be insufficient to explore the relationship between body composition and PF growth. The higher BMI observed in the higher trajectories in our study may be due to a higher percentage of fat-free mass in these individuals rather than obesity. This can be supported by previous results obtained in this same cohort where individuals in the highest tertile of fat mass at 18 and 22 years old presented poorer PF at age 22 years compared to those who were in the lowest tertile \[[@C36]\].

More active people were associated with the LT of FEV~1~/FVC ratio. Physical activity defined by accelerometry has been linked to better PF at 15 years \[[@C37]\]. However, earlier work in our cohort \[[@C38]\] showed no evidence that more active individuals have better PF at 18 years. We only assessed physical activity through self-report and only during commuting and in leisure time. Although we do not refute the possibility of reverse causation in this relationship, we strongly believe that objective measurements of physical activity may better explain its association with PF.

Our study has some limitations. The first refers to differences between respondents (55.6%) and nonrespondents (44.4%), which showed that our sample included more children from wealthier and more educated mothers. However, this probably will have a very small impact on our results, as the socioeconomic status was weakly related to the PF trajectories. Another limitation is related to the self-reported nature of some variables. Diagnosis of asthma and wheezing may be underestimated and physical activity overestimated. With this, the probability increases of not finding a statistical difference. However, there are also considerable strengths. A cohort of live births, representative of the urban area of the municipality and with high response rates, allows the extrapolation of the results to similar settings. The measurements of PF, by trained personnel, allowed the comparability of assessments. Finally, training and re-training of interviewers and repetition of questions to assess reliability ensured the quality of the information.

Although admittedly exploratory, our study adds to the current knowledge as being the first one to address PF trajectories along with several characteristics accessed from perinatal to early adult age in a middle-income setting. The practical relevance of it is the possibility of screening those who fill a risky profile to low PF trajectories in a crucial period of lung development and consequently prevent future respiratory diseases. After being for many years considered a self-inflicted disease by smokers, we now know from longitudinal studies that COPD burden is also related to many factors during the lifespan that culminates in low PF in young adulthood \[[@C39]\]. In addition, keeping in mind the raising of knowledge that PF tracks throughout life, special attention should be given to those individuals belonging to the low trajectories of PF who consequently present a higher risk of developing respiratory diseases such as COPD later in life \[[@C40]\].

Conclusion {#s4a}
----------

Using data from a population-based birth cohort from Brazil, we identified three PF trajectories (low, average and high) in the following parameters: FEV~1~, FVC and FEV~1~/FVC ratio, which tracked from the middle of adolescence to the onset of adult life. They were related to different characteristics, including pregestational BMI, birth weight, hospitalisations due to respiratory diseases in childhood, participant\'s BMI along with follow-ups, report of wheezing, medical diagnosis and family history of asthma, gestational exposure to tobacco and active smoking in adolescence and young adulthood. Public health policies can be planned to control or at least minimise the exposure to such characteristics in order to guarantee that more individuals reach adulthood with ideal values of PF.
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